Stockscreener 앱 받기
1.71
1.72%
-0.03
시간 외 거래:
1.52
-0.19
-11.11%
Nucana Plc Adr 주식(NCNA)의 최신 뉴스
NuCana (NASDAQ: NCNA) outlines 2025 losses, cash and oncology pipeline risks - Stock Titan
Why is NuCana ADR stock down today? - Traders Union
Bearish technicals, heavy selling: NuCana stock slips 3.10% - Traders Union
NuCana stock slips 4.3% as bearish momentum builds ahead of earnings - Traders Union
What triggered NuCana shares' latest price pullback - Traders Union
Sustained bearish momentum and oversold signals — NuCana stock gains 3.14% - Traders Union
Why is NuCana stock up today? - Traders Union
NuCana shares see a dip — What is pressuring the stock - Traders Union
NuCana stock: Persistent volatility and downside risk drive further weakness - Traders Union
Oversold signals and resistance at $2.29 — NuCana stock gains 3.08% - Traders Union
Bearish technical signals persist — NuCana stock drops 3.52% - Traders Union
Persistent bearish signals and technical resistance — NuCana stock drops 4.63% - Traders Union
NuCana sees a dip — What is pressuring the stock - Traders Union
NuCana stock price forecast: Bear signals weigh as NCNA dips beneath key levels - Traders Union
NCNA Fundamental Analysis | NUCANA PLC-ADR (NASDAQ:NCNA) - ChartMill
Weak technical signals and persistent selling — NuCana stock falls 4.02% - Traders Union
What is behind NuCana recent drop in value today - Traders Union
What triggered NuCana latest price surge - Traders Union
NuCana stock: persistent negative momentum drives 3.40% gain despite mixed technicals - Traders Union
NuCana climbs today: Key reasons behind the rally - Traders Union
Buying pressure lifts NuCana higher in today trading - Traders Union
NuCana slides today: Key reasons behind the decline - Traders Union
NuCana stock price forecast: Further downside risk as NCNA drops 3.75% near support levels - Traders Union
NuCana stock: Bearish trends and weak support drive continued price decline - Traders Union
Deeply oversold RSI and bearish technicals — NuCana stock gains 3% - Traders Union
-5.76% for NuCana stock — oversold levels signal persistent bearish pressure - Traders Union
-5.45% for NuCana stock — technical signals warn of limited upside potential - Traders Union
Here’s why NuCana is sliding (January 26) - Traders Union
NuCana is falling today: what traders are watching (January 9) - Traders Union
NuCana stock price forecast: Sellers remain in control as NCNA edges toward support - Traders Union
NuCana stock drops 2.16% as sellers dominate below key moving averages - Traders Union
NuCana stock price forecast: rangebound days expected as NCNA holds steady near resistance - Traders Union
NuCana Appoints Theresa Bruce as Chief Operating Officer - GlobeNewswire Inc.
NuCana appoints Theresa Bruce as chief operating officer - Investing.com
NuCana (NASDAQ:NCNA) Trading Up 1.6% – Here’s Why - Defense World
NuCana plc ADR (NCNA) Stock Price Prediction for 2026, 2030-2040 - Traders Union
NuCana plc ADR (NCNA) Stock Price Prediction: Today, Tomorrow, Next Week - Traders Union
NuCana reports partial responses in melanoma treatment trial - Investing.com
NuCana stock rises after securing key patent in China for cancer drug - Investing.com
Taking the lead: NuCana plc ADR (NCNA) - Setenews
NuCana regains Nasdaq compliance, extends cash runway into 2029 - Investing.com
Wall Street Today: Dow, Nasdaq, S&P 500 open flat as investors focus on China tariff deadline; Nvidia down 1.3% - Mint
NuCana plc Announces Change in American Depository Shares Ratio to Enhance Liquidity and Nasdaq Compliance - Quiver Quantitative
NuCana Cancels Series A Warrants Post-ATM Execution - The Globe and Mail
NuCana completes cancellation of all remaining Series A Warrants - Investing.com
NuCana Announces ADS Ratio Change to Enhance Liquidity - The Globe and Mail
NuCana to implement 1:200 reverse ADS split to boost share price - Investing.com
NuCana (NCNA) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat
NCNA Gets Second Nasdaq Notice; Hearing to Delay Potential Delisting - Stock Titan
NuCana enters $100 million at-the-market sales agreement for ADS offering - Investing.com
NuCana CEO takes leave of absence due to health reasons - Investing.com
nucana plc announces annual report release and upcoming agm - Investing.com
NuCana's Melanoma Breakthrough: Key Drug Advances to Expansion Trial, Q1 Losses Drop 63% Year-over-Year - Stock Titan
NuCana prices $7 million direct offering of ADSs and warrants - Investing.com
Will Pfizer's Non-COVID Drugs Drive Sales Again This Earnings Season? - Zacks Investment Research
RLYB Ends Pregnancy-Related Rare Disease Program, Stock Tanks - Yahoo Finance
NuCana Stock Soars 151% on Upbeat Efficacy Data From Melanoma Study - Yahoo Finance
NCNANuCana plc ADR Earnings - Finviz
NuCana stock downgraded by William Blair after halted cancer study - Investing.com
Nucana Plc Share Price (NCNA.US) - London South East
NuCana shares receive $150 stock PT at Oppenheimer on upbeat trial prospects - Investing.com
NuCana (NCNA) Stock Trends and Sentiment 2026 - MarketBeat
NuCana (NCNA) Stock Forecast and Price Target 2026 - MarketBeat
1.20%
0.06%
자본화:
|
볼륨(24시간):